e.g. Tata motors, Reliance MF, 500570

Nippon India Pharma Fund - Growth

Equity Pharma Very High

NAV on (09 Apr 2025 )

₹461.75

(-1.16%)

Fund Size

₹8080.97 Crores

1Y Returns

6.85 %

 

 

Investment Objective

The primary investment objective of the scheme is to seek to generate continuous returns by investing in equity and equity related or fixed-income securities of Pharma and other associated companies.

AMC

Nippon Life India Asset Management Ltd.

Fund Details

Launch Date

June 5, 2004

Fund Manager

Mr. Sailesh Raj Bhan

Initial Price

10

AUM Fund

8080.97 Cr

Min investment

Rs 5000

Expense Ratio

1.82%

SIP Minimum Investment

(1) Rs.100/- per month and in multiples of Re. 1/- thereafter for minimum 60 months.(2) Rs.500/- per month and in multiples of Re. 1/- thereafter for minimum 12 months.(3) Rs.1,000/- per month and in multiples of Re. 1/- thereafter for minimum 6 months.(4) Rs.500/- per quarter and in multiples of Re. 1/- thereafter for minimum 12 quarters.(5) Rs.1,500/- per quarter and in multiples of Re. 1/- thereafter for minimum 4 quarters.(6) Rs.5,000/- per year and in multiples of Rs. 500/- thereafter for minimum 2 years.

Exit Load

1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.

Nippon India Pharma Fund - Growth - Invest

1 Month

-1.33%

6 Months

-12.88%

1 Year

6.85%

2 Years

29.61%

3 Years

15.91%

5 Years

21.95%

Equity / Mid Cap funds 1Y 3Y Fund Size (Cr)
21.79% 0.00% ₹1634.08
21.79% 0.00% ₹1634.08
21.47% 0.00% ₹271.36
20.32% 0.00% ₹1634.08
20.32% 0.00% ₹1634.08
Address
4th Floor, Tower A,Peninsula Business Park,Ganapatrao Kadam Marg,Lower Parel (W), Mumbai Maharashtra India 400013
Phone
+91 22 68087000
Fax
+91 22 68087097
Launch Date
June 5, 2004
Custodian
Deutsche Bank AG
Registrar & Transfer Agent
KFIN Technologies Pvt. Ltd.
Close

Add Nippon India Pharma Fund to your Watchlist

Alert me if price...
Close

Add Nippon India Pharma Fund to your Portfolio

:  
   
: